Glen David
Chief Financial Officer
Replay available
Phibro Animal Health Corporation (NASDAQ: PAHC) Q4 2025 earnings conference call, held 2025-08-28. Replay captured from the company's public earnings webcast.

Chief Financial Officer
Chairman, President, and Chief Executive Officer
Director and Executive Vice President of Corporate Strategy
Chief Operating Officer
Analyst, Morgan Stanley
Analyst, JP Morgan
Analyst, Bank of America
Analyst, BNP Paribas
Hello and thank you for standing by. My name is Regina and I will be your conference operator today. At this time, I would like to welcome everyone to the Fibro Animal Health Corporation fourth quarter and fiscal year 2025 results webcast and conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star then the number one on your telephone keypad. To withdraw your question, press star 1 again. I would now like to turn the conference over to Glen David, Chief Financial Officer. Please go ahead. Thank you, Regina. Good day, and welcome to the Fibro Animal Health Corporation earnings call for our fiscal fourth quarter and full year ending June 30th, 2025. My name is Glen David, and I am the Chief Financial Officer of Fibro Animal Health Corporation. I am joined on today's call by Jack Bentime, Fibro's Chairman President and Chief Executive Officer, Donnie Bentime, Director and Executive Vice President of Corporate Strategy, and Larry Miller, Chief Operating Officer. Today, we will cover financial performance for our fourth quarter and full year 2025 and provide financial guidance for our fiscal year ending June 30th, 2026. At the conclusion of our remarks, we will open the line for your questions. I would like to remind you that we are providing a simultaneous webcast of this call on our website, pahc.com. Also, on the investor section of our website, you will find copies of the earnings press release and annual Form 10-K, as well as the transcript and slides discussed and presented on this call. Our remarks today will include forward-looking statements, and actual results could differ materially from t...